Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of efficacy of Peganum harmala extract on patients with head lice
IRCT20160306026938N12Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Peganum harmala extract in pediculosis capitis, sponsored by Tehran University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
Peganum harmala extract
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on IRCT20160306026938N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160306026938N12.